“…In an early work from 1983, Groschel (122) explained somewhat prophetically the use of antibodies in clinical microbiology. FCM in conjunction with fluorescent antibodies has been used to detect surface antigens in Haemophilus (298), Salmonella (57,207), Mycobacterium (238), Brucella (35), Branhamella catarrhalis (29), Mycoplasma fermentans (50), Pseudomonas aeruginosa (134), Bacteroides fragilis (191,239) and Legionella (143), among other microorganisms. These examples illustrate the sensitivity and specificity of using antibodies that allow the detection of particular cell types (of as few as 100 cells per ml in 30 min) in heterogeneous populations (57).…”